期刊文献+

胃滞留给药系统的研究进展 被引量:11

Progress in development of gastroretentive drug delivery system
原文传递
导出
摘要 胃滞留给药系统能延长药物在胃内的滞留时间、增加药物在胃肠道的吸收、减少给药次数、增加患者的耐受性、提高临床疗效,是一种理想的给药系统。通过查阅国内外相关文献,本文从作用机制及制剂因素等几方面,对目前发展较好的几种胃滞留给药系统进行综述,并对新材料以及纳米技术在胃滞留给药系统中的应用给予简单的介绍。同时结合近几年胃滞留给药的研究热点,对胃滞留给药系统的发展前景进行概述。 Gastroretentive drug delivery system enhances residence time and the degree of drug absorption in the gastrointestinal tract,decreases the times of taking medicine,increases the tolerance of the patients,and improves the clinical curative effect. Thus,it is an ideal drug delivery system. In this review,we summarized the mechanism and the preparation factors of several currently developed kinds of gastroretentive drug delivery system.We also gave a brief introduction of the new materials and the application of nanotechnology in gastroretentive drug delivery system. At the same time,we described the hotspots of gastroretentive dose forms and revealed their wide application prospects.
出处 《中国新药杂志》 CAS CSCD 北大核心 2017年第4期420-426,共7页 Chinese Journal of New Drugs
关键词 口服缓控释制剂 胃滞留给药系统 超多孔水性凝胶给药系统 协同型胃滞留给药系统 oral sustained and controlled release preparations gastroretentive drug delivery system super poroushydrogels gastroretentive drug delivery systems with several synergistic principles
  • 相关文献

参考文献2

二级参考文献29

  • 1Jiang T Y, Zhang Z H, Zhang Y L, et al. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery[J]. Biomaterials, 2012, 33(36) 9246-9258.
  • 2Huo M R, Zou A F, Yao C L, et al. Somatostatin receptor-mediated tumor-targeting drug delivery using octreotide-PEG-deoxycholicacid conjugate-modified N-deoxycho -lic acid-O,N-hydroxyethylation chitosan micelles[J]. Biomaterials, 2012; 33(27): 6393-6407.
  • 3Liang N, Sun S P, Li X F, et al. a-Tocopherol succinate-modified chitosan as a micellar delivery system for paclitaxel: preparation characterization and in vitroin vivo evaluations[J]. Int J Pharm, 2012, 423(2):480-488.
  • 4Wei M Y, Xu Y H, Zou Q, et al. Hepatocellular carcinoma targeting effect of PEGylated liposomes modified with lactoferrin[J]. Eur d Pharm Sci, 2012, 46(3): 131-141.
  • 5Zhu K, Guo C F, Lai H, et al. Novel hyperbranched polyamidoamine nanoparticle based gene delivery: transfection, cytotoxicity and in vitro evaluation[J]. Int J Pharm, 2012, 423(2):378-383.
  • 6Zhan C Y, Wei X L, Qian J, et al. Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo[J]. J Controlled Release, 2012, 160(3): 630-636.
  • 7Li X J, Chang S, Dua G S, et al. Encapsulation of azithromycin into polymeric microspheres by reduced pressure-solvent evaporation method[J]. IntJPharm, 2012, 433(1/2): 79-88.
  • 8Cui D C, Lu W L, Sa E A, et al. Poly(acrylic acid) microspheres loaded with lidocaine: preparation and characterizat- ion for arterial embolization[J], lnt.lPharm, 2012, 436(1/2): 527-535.
  • 9Xin C, Wang L H, Yue Y, et al. A novel method to enhance the efficiency of drug transdermal iontophore- sis delivery by using complexes of drug and ion-exchange fibers[J], lntdPharm, 2012, 428(1/2): 68-75.
  • 10Cai H, Ni C H, Zhang L P. Preparation of complex nano-particles based on alginic acid/poly[(2-dimethylamino) ethyl methacrylate] and a drug vehicle for doxorubicin release controlled by ionic strength[J]. Eur J Pharm Sci, 2012 ( 45 ) : 43-49.

共引文献10

同被引文献85

引证文献11

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部